ctDNA Assay May Elucidate Outcomes With Chemo in HR+ Breast Cancer
Future research will focus on ctDNA dynamics change over time in the full translational cohort of patients with hormone receptor–positive breast cancer in the phase 3 monarchE study, says Stephanie L. Graff, MD.